Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference109 articles.
1. Classification and pathology of lung cancer;Zheng;Surg. Oncol. Clin.,2016
2. Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC);Barr Kumarakulasinghe;Respirology,2015
3. Identifying cancer origin using circulating tumor cells;Lu;Cancer Biol. Ther.,2016
4. Early lung cancer with lepidic pattern: adenocarcinoma: in situ:, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma;Weichert;Curr. Opin. Pulm. Med.,2014
5. Adenocarcinoma classification: patterns and prognosis;Kuhn;Pathol. J. Ital. Soc. Anatom. Pathol. Diagnost. Cytopathol.,2018
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine;Frontiers in Pharmacology;2024-01-19
2. What's new in thoracic oncology;Journal of Surgical Oncology;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3